Microbio Co., Ltd. (TPEX:4128)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
23.65
+0.10 (0.42%)
Aug 12, 2025, 12:59 PM CST
0.42%
Market Cap13.85B
Revenue (ttm)1.77B
Net Income (ttm)-1.11B
Shares Out588.17M
EPS (ttm)-1.89
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,000
Average Volume1,712,695
Open23.55
Previous Close23.55
Day's Range23.50 - 23.80
52-Week Range20.00 - 45.00
Beta0.60
RSI46.34
Earnings DateAug 11, 2025

About Accolade

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is base... [Read more]

Founded 2000
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4128
Full Company Profile

Financial Performance

In 2024, Microbio's revenue was 1.72 billion, an increase of 8.26% compared to the previous year's 1.59 billion. Losses were -1.10 billion, -6.70% less than in 2023.

Financial Statements

News

There is no news available yet.